blank
blank

Your Tag: Drug Repurposing

ERDERA News (1)

ERDERA Clinical Trial Call 2026: pre‑announcement and key dates

ERDERA will launch its Clinical Trial Call 2026 (ECTC) on 1 July 2026, supporting multinational, GCP‑compliant early‑phase interventional clinical trials in rare diseases.
ERDERA CTC 2026

ERDERA Clinical Trial Call 2026 – Pre-announcement

Pre-announcement describing scope, eligibility and indicative timeline for the ERDERA Clinical Trial Call 2026, expected to open on 1 July 2026.
ERDERA CTC 2026

Example of costing of Clinical Trial Budget

Budget example showing low and high cost ranges for a Phase 1 rare disease clinical trial with twenty subjects.
ERDERA CTC 2026

ERDERA Clinical Trial Call 2026 – Call Text

Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026. [ERDERA_Cli...t_20260603 | PDF]
#iDR26 Why Join Carousel_page-0006

#iDR26 International Drug Repurposing Conference: Navigating the future

May 12 - May 13
Join the leading international drug repurposing conference to explore the future of patient-centric medicines repurposing!
Exterior of European Medicines Agency in Amsterdam

EMA concludes pilot to support repurposing of established medicines

Accelerating evidence-driven innovation to unlock fresh indications for established therapies.
Irene Norstedt

Irene Norstedt: “The EU supports collaboration because no country alone, and no stakeholder alone, has the answer for such huge unmet needs in rare disease research”

ERDERA interviews Irene Norstedt, Director for the People Directorate at DG Research and Innovation in the European Commission.

ERDERA's

search form